A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 154 participants.

Also called NCT05326230

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 154 participants (planned count) (from the registry)
Sponsor
Otsuka Medical Devices Co., Ltd. Japan (from the registry)
Registry
  • NCT NCT05326230
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05326230. Randomized; double masking; primary purpose treatment. Start 2022-07-01 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
Condition
Hypertension
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
Paradise™ (PRDS-001) Renal Denervation Ultrasound System
Intervention (Device)
Renal Angiogram
Lead sponsor
Otsuka Medical Devices Co., Ltd. Japan (class: industry)

Record details

Record id
cardio:ct-nct05326230
Content hash
e0696de5e9ae81997e115ea4122156a3d0c43b33a5b30224780fa22abfc7fe1d